- Location
advanced breast cancer
"-
Advanced Breast Cancer Has Identified Individuals with a Good Chance
Feb 25, 2014The first large-scale study testing all the DNA—the entire genome—of tumour cells from more than 400 women with advanced breast cancer has identified individuals with a good chance of benefiting from specific treatments already ...
Tags: CGH, SAFIR01, DNA, Gustave Roussy
-
Palbociclib Received Breakthrough Therapy Designation by The United States Food
Feb 14, 2014Pfizer Inc. (NYSE:PFE) today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival ...
Tags: Health&Medicine
-
Surgery and Radiation Might Not Benefit Women with Advanced Breast Cancer
Dec 27, 2013After chemotherapy, surgery and radiation to treat the original tumor might not benefit women with advanced breast cancer, a new study shows. A minority of women with breast cancer discover they have the disease in its later stages, after ...
Tags: advanced breast cancer, chemotherapy, original breast tumor, women health
-
Adding Cancer Drug Dasatinib to Therapy May Slow Progression of Advanced Breast Cancer
Dec 26, 2013Adding the cancer drug dasatinib to standard hormone therapy may slow the progression of advanced breast cancer, a preliminary study suggests. The drug, sold under the name Sprycel, is already approved in the United States for chronic ...
Tags: cancer drug, dasatinib, hormone therapy, advanced breast cancer
-
NICE in The UK, Has Issued an Appraisal Consultation Document (ACD)
Mar 26, 2013The National Institute for Health and Clinical Excellence (NICE) in the UK, has issued an Appraisal Consultation Document (ACD) recommending that Afinitor (everolimus), a Novartis’ life extending advanced breast cancer treatment ...
-
Novartis Wins FDA Approval for Afinitor Tablets to Treat Advanced Breast Cancer
Jul 23, 2012Novartis has won FDA approval for Afinitor (everolimus) tablets for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ breast cancer) in combination with exemestane after ...
